Inhibition of the Epstein-Barr virus lytic cycle by protoapigenone

Tung Chao-Ping, Chang Fang-Rong, Wu Yang-Chang, Chuang Da-Wei, Hunyadi Attila, Liu Shih-Tung
2011

Discovery of the first non-planar flavonoid that can strongly inhibit xanthine oxidase protoapigenone 1′-O-propargyl ether /

Hunyadi Attila, Martins Ana, Dankó Balázs, Chuang Da-Wei, Trouillas Patrick, Chang Fang-Rong, Wu Yang-Chang, Falkay György
2013

In vitro cytotoxic activity of novel protoflavone analogs – selectivity towards a multidrug resistant cancer cell line

Dankó Balázs Ödön, Martins Ana, Chuang Da-Wei, Wang Hui-Chun, Amaral Leonard, Molnár József, Chang Fang-Rong, Wu Yang-Chang, Hunyadi Attila
2012

Direct semi-synthesis of the anticancer lead-drug protoapigenone from apigenin, and synthesis of further new cytotoxic protoflavone derivatives

Hunyadi Attila, Chuang Da-Wei, Dankó Balázs Ödön, Chiang Michael Y, Lee Chia-Lin, Wang Hui-Chun, Wu Chin-Chung, Chang Fang-Rong, Wu Yang-Chang
2011

Inhibition of ATR-dependent signaling by protoapigenone and its derivative sensitizes cancer cells to interstrand cross-link–generating agents in vitro and in vivo

Wang Hui-Chun, Lee Alan Yueh-Luen, Chou Wen-Cheng, Wu Chin-Chung, Tseng Chao-Neng, Liu Kevin Yen-Ting, Lin Wen-Lien, Chang Fang-Rong, Chuang Da-Wei, Hunyadi Attila, Wu Yang-Chang
2012